Researchers, healthcare experts working to develop COVD-19 vaccine as death toll surges
Scientists at Beth Israel Deaconess Medical Center are in the early stages of developing a vaccine to treat COVID-19. Read Article
This author has not written his bio yet.
But we are proud to say that Morgana Souza contributed 243 entries already.
Scientists at Beth Israel Deaconess Medical Center are in the early stages of developing a vaccine to treat COVID-19. Read Article
“The stunning epidemiology and clinical features of COVID-19, particularly the potential for explosive and asymptomatic spread, increase the chance that a vaccine may actually be required to end this epidemic,” […]
BIOQUAL announces the development of programs for in-vivo testing of COVID-19 candidate vaccines. BIOQUAL’s efforts to develop animal models for COVID-19 began in February 2020 in collaboration with Dr. Dan […]
Dr. Dan Barouch speaks with Lisa Mullins from WBUR about COVID-19 vaccine plans with Johnson & Johnson. Listen more
Clinical trials are set to start by September, and if all goes well, it could be ready for emergency use early next year. Read Article
“The industry in Massachusetts is going to the mat to fight this thing.” Read Article
“And, logically, the larger amount of virus should trigger more severe disease by prompting a brisker inflammatory response. But that is still speculative. The relationship between initial viral dose and […]
Dr. Katy Stephenson speaks to NBC Boston about leading two clinical trials for a treatment for COVID-19 patients. See more
Dr. Katy Stephenson, physician-scientists at Harvard Medical School and Beth Israel Deaconess Medical Center are now enrolling patients in two clinical trials testing treatment options for COVID-19, the illness caused […]

3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]
